美股A股
StockGist
Back
8-K2026-02-20· grok-4-1-fast-non-reasoning

ABUS · Arbutus Biopharma Corporation

0001171843-26-000979

SEC filing

Summary

Arbutus Biopharma Corporation filed an 8-K on February 20, 2026, disclosing a memorandum and order issued by the U.S. District Court for the District of Delaware on February 17, 2026, in litigation filed by Arbutus Biopharma. Exhibit 99.1 contains the court document.

Key takeaways